Access to anti-retroviral drugs, female in Uganda
Uganda: Access to anti-retroviral drugs, female was 88.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Uganda, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
Uganda recorded 88.0% for access to anti-retroviral drugs, female in 2024. That is the highest value across all 25 years on record.
The figure is up 3.5% on the previous year and up 60.0% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Uganda peaked at 88.0% in 2024 and was at its lowest, 0.0%, in 2000.
Uganda ranks 44th of 141 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Uganda, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 1.0% | — |
| 2003 | 2.0% | +100.0% |
| 2004 | 5.0% | +150.0% |
| 2005 | 8.0% | +60.0% |
| 2006 | 8.0% | +0.0% |
| 2007 | 10.0% | +25.0% |
| 2008 | 14.0% | +40.0% |
| 2009 | 15.0% | +7.1% |
| 2010 | 19.0% | +26.7% |
| 2011 | 22.0% | +15.8% |
| 2012 | 33.0% | +50.0% |
| 2013 | 46.0% | +39.4% |
| 2014 | 55.0% | +19.6% |
| 2015 | 58.0% | +5.5% |
| 2016 | 64.0% | +10.3% |
| 2017 | 72.0% | +12.5% |
| 2018 | 76.0% | +5.6% |
| 2019 | 79.0% | +3.9% |
| 2020 | 80.0% | +1.3% |
| 2021 | 81.0% | +1.2% |
| 2022 | 83.0% | +2.5% |
| 2023 | 85.0% | +2.4% |
| 2024 | 88.0% | +3.5% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 6.3% | 0.0% | 15.0% | 10 |
| 2010s | 52.4% | 19.0% | 79.0% | 10 |
| 2020s | 83.4% | 80.0% | 88.0% | 5 |
Countries ranked near Uganda
More gender data for Uganda
- Child population (UN estimates and projections) 23,854 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 1.35 % change on previous year (2030)
- Population 34,459 (2030)
- Working-age population (UN estimates and projections) 34,459 (2030)
- Population (UN estimates and projections), annual growth rate 3.21 % change on previous year (2030)
- Age population, age 00, female, interpolated 832,544 (2025)
- Age population, age 00, male, interpolated 852,069 (2025)
- Age population, age 01, female, interpolated 821,106 (2025)
- Age population, age 01, male, interpolated 839,557 (2025)
- Age population, age 02, female, interpolated 810,014 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Uganda?
- Access to anti-retroviral drugs, female in Uganda was 88.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Uganda?
- The highest recorded value was 88.0% in 2024.
- What is the lowest access to anti-retroviral drugs, female recorded in Uganda?
- The lowest recorded value was 0.0% in 2000.
- How does Uganda rank for access to anti-retroviral drugs, female?
- Uganda ranks 44th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Uganda?
- Over the last ten years it is up 60.0%. The long-run trend across the full record is volatile.
- Where does this Uganda data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.